In this issue, as well as in the next issue of the Journal of Innate Immunity, a series of review articles on NK cells is published, summarizing some of the recent research activities within this growing field of research. Several leading scientists have made seminal contributions to the two issues. In the first issue (Vol. 3, Issue 3, 2011), a series of reviews relating to the molecular specificity of NK cells, including studies of their receptors and receptor signaling, is presented. These are followed by a series of reviews that discuss NK cell interactions with other immune cells and NK cell responses to infections. In the second issue (Vol. 3, Issue 4, 2011), we will publish reviews relating to the life span of NK cells, their development, differentiation and senescence. NK cell interactions with tumor cells will also be reviewed, as well as new insights into hematopoietic stem cell transplantations where NK cells may contribute to tumor eradication. Finally, two reviews will cover the role of NK cells in organ transplant rejection and in an inflammatory disease setting.
The first review in this series of articles is an update on the molecular mechanisms for NK cell activation. With an array of activating and inhibitory receptors, Bryceson et al. [11] describe how NK cells upon target cell engagement can specifically get activated to eradicate infected and transformed cells. Likewise, it is described how similar receptors control the production of chemokines and cytokines, fulfilling important tasks in conIn the beginning of the 1970s, a number of groups observed unexpected spontaneous cytotoxic activities among lymphocytes. While at first considered as 'annoying' background phenomena, subsequent studies led to the realization that a new subpopulation of lymphocytes could be linked to this activity [1, 2] . The cells were termed 'natural killer' or, briefly, 'NK' cells [2] . Studies of these cells initially engaged a rather small community of scientists, who often had to fight for their existence among other fellow immunologist, many of whom were studying the more 'sophisticated' adaptive immune cells -the T cells and B cells. However, growing insights into the molecular specificity of NK cells [3] [4] [5] , and insights into their role in controlling virus and intracellular bacteria infections, certain tumors and their ability to regulate other immune cells, hence affecting complex diseases such as autoimmune and hypersensitivity conditions, have put NK cells in the front seat of modern immunology [6] . New insights are rapidly attributing new features to the cells, e.g. a possible role in controlling T-cell and macrophage homeostasis [7] and possibilities to use them in therapeutic settings of cancer [8] . Furthermore, the recent identification of adaptive immune cell features of NK cells is a 'hot topic' at the moment [9] . Studies of NK cells now engage a large community of scientists, working in diverse areas of NK cell research, in experimental model systems as well as in humans [10] . [14] , in a comprehensive way, review recent advances in our understanding of the architecture of the regulatory regions within KIR genes and discuss a potential role for non-coding RNA in KIR transcriptional regulation during NK cell development. A substantial body of evidence has demonstrated that a family of PI3K isoenzymes, which mediate the interchange of phosphates on inositol phospholipid species at the plasma membrane, have a prominent role in NK cell biology, affecting cell growth, survival, proliferation and motility of the cells. Kerr and Colucci [15] nicely cover this topic. An extensively studied feature of NK cells is their interactions with other immune cells including cells of the myeloid linage. Wehner et al. [16] summarize recent studies on the bidirectional crosstalk between human dendritic cells (DCs) and NK cells. They discuss how the reciprocal activation of DCs and NK cells, upon contact between the two cells, may play a pivotal role in the immune defense against viruses and tumors. On a similar theme, Seya et al. [17] discuss recent advances related to DC-mediated NK cell activation. In particular, they discuss how DCs, in response to 'microbial patterns', by virtue of cytokine production and other cytokine-independent means participate in driving NK cell activation. As alluded to, one of the hallmarks of NK cells is their ability to respond to viral infections. Brandstadter and Yang [18] provide an overview of how NK cells are activated in response to viral infections and continue to discuss the recruitment of activated NK cells to the site of infection, and then discuss NK cell effector mechanisms against virally infected cells. Covering an area that has not so often been reviewed in the past, Guilmot et al. [19] discuss NK cell responses to infections in early life. They summarize the phenotype and functional abilities of NK cells from healthy infants, and NK cell responses against viral, bacterial and protozoan infections early in life. In a final paper in this first issue on NK cells, Naper et al. [20] discuss the role of NK cells in controlling a bacterial infection. They take the discussion from the point of view of their own studies in the rat as an experimental model and compare results with others in the mouse model. Clearly, research on NK cells is expanding in a way not seen in the past. It is our hope that the interested reader will become up to date with some of the very many interesting topics of research that the NK cell field has to offer. Yet more topics will be covered in the next issue of this journal. Enjoy!
